UnitedHealth Group Incorporated $UNH Shares Sold by Migdal Insurance & Financial Holdings Ltd.

Migdal Insurance & Financial Holdings Ltd. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 9.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,263 shares of the healthcare conglomerate’s stock after selling 133 shares during the quarter. Migdal Insurance & Financial Holdings Ltd.’s holdings in UnitedHealth Group were worth $394,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in UNH. Caitlin John LLC grew its position in UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after buying an additional 111 shares during the last quarter. Triumph Capital Management acquired a new position in UnitedHealth Group in the second quarter worth approximately $1,324,000. Wealth Effects LLC grew its position in UnitedHealth Group by 14.4% in the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after buying an additional 591 shares during the last quarter. Arlington Partners LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth approximately $2,229,000. Finally, Folger Nolan Fleming Douglas Capital Management Inc. grew its position in UnitedHealth Group by 14.6% during the 2nd quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 28,798 shares of the healthcare conglomerate’s stock worth $8,984,000 after purchasing an additional 3,660 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on UNH shares. Leerink Partners set a $410.00 price objective on shares of UnitedHealth Group and gave the stock an “outperform” rating in a research report on Wednesday. Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Deutsche Bank Aktiengesellschaft cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective on the stock. in a research report on Wednesday. Truist Financial lifted their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Finally, The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 target price for the company. Eighteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $395.64.

UnitedHealth Group Stock Down 3.2%

UnitedHealth Group stock opened at $356.05 on Thursday. The company has a market capitalization of $322.47 billion, a P/E ratio of 18.58, a P/E/G ratio of 2.37 and a beta of 0.47. The firm’s fifty day simple moving average is $342.00 and its 200-day simple moving average is $331.00. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter last year, the firm earned $7.15 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.